<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Themis Medicare Limited — News on 6ix</title>
<link>https://6ix.com/company/themis-medicare-limited</link>
<description>Latest news and press releases for Themis Medicare Limited on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 19 Nov 2024 02:01:20 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/themis-medicare-limited" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo683651a978dffbe2df155cb8.webp</url>
<title>Themis Medicare Limited</title>
<link>https://6ix.com/company/themis-medicare-limited</link>
</image>
<item>
<title>Press Release Nov 18 2024</title>
<link>https://6ix.com/company/themis-medicare-limited/news/press-release-nov-18-2024-14</link>
<guid isPermaLink="true">https://6ix.com/company/themis-medicare-limited/news/press-release-nov-18-2024-14</guid>
<pubDate>Tue, 19 Nov 2024 02:01:20 GMT</pubDate>
<description>Themis Medicare Limited has informed the Exchange regarding a press release dated November 18, 2024, titled "Submission of Press Release".</description>
</item>
<item>
<title>Press Release Nov 10 2023</title>
<link>https://6ix.com/company/themis-medicare-limited/news/press-release-nov-10-2023-21</link>
<guid isPermaLink="true">https://6ix.com/company/themis-medicare-limited/news/press-release-nov-10-2023-21</guid>
<pubDate>Fri, 10 Nov 2023 20:04:41 GMT</pubDate>
<description>Themis Medicare Limited has informed the Exchange regarding a press release dated November 10, 2023, titled " Themis Medicare Launches REMITHEM�� REMIFENTANIL Injection A Novel Narcotic Analgesic for use during induction of anesthesia, during immediate post-operative period and in monitored anesthesia care .".</description>
</item>
<item>
<title>Press Release Feb 17 2023</title>
<link>https://6ix.com/company/themis-medicare-limited/news/press-release-feb-17-2023-13</link>
<guid isPermaLink="true">https://6ix.com/company/themis-medicare-limited/news/press-release-feb-17-2023-13</guid>
<pubDate>Fri, 17 Feb 2023 15:51:36 GMT</pubDate>
<description>Themis Medicare Limited has informed the Exchange regarding a press release dated February 16, 2023, titled "Themis Medicare announces DCGI approval of Remifentanil Hydrochloride 1mg/2mg for injection for import and marketing.".</description>
</item>
<item>
<title>Press Release Jan 03 2023</title>
<link>https://6ix.com/company/themis-medicare-limited/news/press-release-jan-03-2023-8</link>
<guid isPermaLink="true">https://6ix.com/company/themis-medicare-limited/news/press-release-jan-03-2023-8</guid>
<pubDate>Tue, 03 Jan 2023 23:14:54 GMT</pubDate>
<description>Themis Medicare Limited has informed the Exchange regarding a press release dated January 03, 2023, titled " Themis Medicare Launches Lenzetto�� Global brand of Estradiol Novel Drug Delivery System for treatment of Menopausal symptoms .".</description>
</item>
<item>
<title>Press Release Nov 08 2022</title>
<link>https://6ix.com/company/themis-medicare-limited/news/press-release-nov-08-2022-17</link>
<guid isPermaLink="true">https://6ix.com/company/themis-medicare-limited/news/press-release-nov-08-2022-17</guid>
<pubDate>Wed, 09 Nov 2022 00:06:44 GMT</pubDate>
<description>Themis Medicare Limited has informed the Exchange about press release dated 08-Nov-2022 titled Financial Results for the Half year ended 30th September, 2022</description>
</item>
<item>
<title>Press Release Oct 06 2022</title>
<link>https://6ix.com/company/themis-medicare-limited/news/press-release-oct-06-2022-11</link>
<guid isPermaLink="true">https://6ix.com/company/themis-medicare-limited/news/press-release-oct-06-2022-11</guid>
<pubDate>Thu, 06 Oct 2022 21:42:31 GMT</pubDate>
<description>Themis Medicare Limited has informed the Exchange about press release dated 06-Oct-2022 titled THEMIS MEDICARE PARTNERS WITH NFL BIOSCIENCES FOR THE DEVELOPMENT OF NFL-101 IN INDIA</description>
</item>
<item>
<title>Press Release May 18 2022</title>
<link>https://6ix.com/company/themis-medicare-limited/news/press-release-may-18-2022-13</link>
<guid isPermaLink="true">https://6ix.com/company/themis-medicare-limited/news/press-release-may-18-2022-13</guid>
<pubDate>Wed, 18 May 2022 15:22:26 GMT</pubDate>
<description>Themis Medicare Limited has informed the Exchange about press release dated 18-May-2022 titled Receipt of add on approval for our drug VIRALEX for the treatment of Influenza and other Acute Viral Respiratory Infections (AVRI), Mucocutaneous herpes, Genital wart and Subacute Sclerosing Panenceph</description>
</item>
<item>
<title>Press Release Mar 21 2022</title>
<link>https://6ix.com/company/themis-medicare-limited/news/press-release-mar-21-2022-14</link>
<guid isPermaLink="true">https://6ix.com/company/themis-medicare-limited/news/press-release-mar-21-2022-14</guid>
<pubDate>Mon, 21 Mar 2022 15:05:26 GMT</pubDate>
<description>Themis Medicare Limited has informed the Exchange about press release dated 21-Mar-2022 titled Indian regulator approves VIRALEX for the treatment of mild to moderate COVID-19 in India</description>
</item>
<item>
<title>Press Release Mar 03 2022</title>
<link>https://6ix.com/company/themis-medicare-limited/news/press-release-mar-03-2022-12</link>
<guid isPermaLink="true">https://6ix.com/company/themis-medicare-limited/news/press-release-mar-03-2022-12</guid>
<pubDate>Thu, 03 Mar 2022 23:34:58 GMT</pubDate>
<description>Themis Medicare Limited has informed the Exchange about press release dated 03-Mar-2022 titled Indian regulator approves VIRALEX for the treatment of mild to moderate COVID-19 in India</description>
</item>
<item>
<title>Press Release Feb 15 2022</title>
<link>https://6ix.com/company/themis-medicare-limited/news/press-release-feb-15-2022-9</link>
<guid isPermaLink="true">https://6ix.com/company/themis-medicare-limited/news/press-release-feb-15-2022-9</guid>
<pubDate>Tue, 15 Feb 2022 21:49:43 GMT</pubDate>
<description>Themis Medicare Limited has informed the Exchange regarding a press release dated February 11, 2022, titled "Media Release - Financial Results for the third Quarter ended 31st December 2021.".</description>
</item>
</channel>
</rss>